ily, 13 after binding of its tandem Src homology-2 (SH2)
teins would then be recruited on tyrosine phosphorylated Syk, thereby triggering the formation of elaborate multimolecular complexes linking the stimulated BCR to downstream Introduction biochemical pathways. 5, 6 Tyrosine phosphorylation of Syk therefore appears to be a central event in the BCR signaling Chronic lymphocytic leukemia (CLL) is characterized by pathway. We investigated whether a defect in the coupling clonal proliferation and accumulation of neoplastic B lymphoof Syk was involved in the observed alteration of membrane cytes in blood, bone marrow, lymph nodes and spleen. 1 These Ig signaling in B-CLL cells. cells have a characteristic immunophenotype, including lowdensity surface membrane immunoglobulin (mostly IgM and IgD, with a single light chain kappa or lambda), 2 and expression of CD19, CD23 and CD20 cell-surface antigens, 3 and, in most cases, CD5 surface expression. 4 In normal resting Materials and methods B lymphocytes, stimulation of the antigen-specific receptor (BCR) is a key trigger of engagement into the G1 phase of the cell-cycle. This stimulation results in early biochemical Cells changes dominated by rapid tyrosine phosphorylation of numerous substrates, generating signaling cascades downstream of the BCR; these steps, such as the intracellular calLymphocytes of the Daudi B cell line were cultured in RPMI cium (Ca 2+ ) increase provoked by BCR ligation, are involved 1640 medium containing 10% FCS, 2 mM L glutamine, 1% Na in the activation process that can culminate in proliferation of pyruvate and antibiotics (complete culture medium). B-CLL stimulated cells (reviewed in Refs 5 and 6). It has long been cells were obtained from peripheral blood of CLL patients with known that stimulated proliferation of the monoclonal B cell their informed consent. The cells were isolated by Ficollpopulation from some patients with CLL is impaired. 7, 8 More Hypaque gradient centrifugation (Pharmacia, Paris, France), recently, it was demonstrated that production of the Ca 2+ washed once and maintained for 1 h at 37°C in complete culsecond messenger inositol 1,4,5-trisphosphate (IP 3 ) in ture medium before use. Some experiments were performed response to BCR stimulation was defective in some B-CLL with B-CLL cells maintained in culture medium at 4°C overcells, and, accordingly, that their Ca 2+ response was pronight. Normal B cells were isolated from tonsils obtained durfoundly reduced.
9 This suggested that a preferential change in ing tonsillectomy. After teasing, mononuclear cells were recothe Ca 2+ signaling pathway explained the unresponsiveness of vered by Ficoll-Hypaque centrifugation. B cells were some B-CLL cells. It was confirmed by the observation that negatively purified by incubating the cell suspension with tyrosine phosphorylation of phospholipase C gamma (PLC␥) saturating concentrations of specific monoclonal antibodies (mAb) against CD2 (mAb T11; Coulter, Margency, France) and CD16 (mAb 3G8; Immunotech, Marseille, France) for 30 min Antibodies buffer supplemented with ATP 10 M, 5 Ci of ␥-32 P ATP (4500 Ci/mmol; ICN Biomedicals France, Orsay, France). After 5 min at 30°C, the reaction was stopped by the addition Rabbit polyclonal antibodies against human IgM were from Jackson ImmunoResearch Laboratories (West Grove, PA, of 50 l of SDS sample buffer and boiling. Proteins were separated by 10% SDS-PAGE and quantitation of radioactivity USA). The mAb 4G10, against phosphotyrosine, was from Upstate Biotechnology Incorporated (Lake Placid, NY, USA).
was achieved by transferring the dried gel to a high resolution ␤-imager (Biospace, Paris, France) allowing us to obtain a Rabbit polyclonal antiserum against the ␥-2 isoform of PLC␥ was from Santa Cruz Biotechnology (Tebu, Le Perray en Yveldigital autoradiogram and quantitate signals by direct measurement of numeric images obtained from actual counines, France). Rabbit antiserum against rat Syk2, kindly provided by Dr M Benhamou (CNRS URA 625, Paris, France) has ting of ␤-particles emitted. been described elsewhere. 16 It was raised against a synthetic peptide (CAVELRLRNYYYDVVN), corresponding to the carboxy-terminal region of the kinase.
Ca
2+ measurements
Intracellular Ca 2+ was measured as previously described.
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Analysis of tyrosine phosphorylation Briefly, cells (5 × 10 6 ) were washed once and loaded with 5 M fura2/AM in 300 l of 50 mM HEPES buffer, pH 7.2, supDaudi B cells and B-CLL cells were washed with 10 mM plemented with 120 mM NaCl, 1 mM CaCl 2 , 0.5 mM MgCl 2 , HEPES serum-free RPMI 1640 medium and resuspended at a 5 mM KCl, 1 mM Na 2 HPO 4 and 1 mg/ml glucose. After 20 min density of 1 or 2 × 10 7 cells/500 l of the same medium, and incubation at 37°C, the cell suspension was diluted with 6 ml stimulated with rabbit anti-IgM for 2 min at 37°C. Reactions of the same buffer and reincubated for 20 min at 37°C. Cells were stopped by rapid centrifugation and the pellets were were then centrifuged and the pellet was resuspended in 2 ml resuspended in 150 l of lysis buffer (Tris 20 mM, pH 7.5, of the same buffer. The fluorescence of the cell suspension EDTA 1 mM, NaCl 140 mM, aprotinin 50 U/ml, PMSF 1 mM, was monitored in quartz cuvettes thermostated at 37°C in a sodium orthovanadate 1 mM) containing 1% of Brij 96 deterPerkin-Elmer LS-5B luminescence spectrometer (Perkin Elmer, gent (polyoxyethylene 10 oleyl ether) for 60 min at 4°C. Cell Bois d'Arcy, France). The cell suspension was excited alterdebris was removed by centrifugation at 12 000 g and the nately at 340 and 380 nm and fluorescence was measured at detergent-soluble fraction was boiled in sample buffer. Solubi-510 nm. 
, published trotransferred to nitrocellulose membranes (Schleicher and by Grynkiewicz et al. 18 For each B-CLL cell, R min and R max Schuell, Dassel, Germany) for 80 min at 65 V. The blots were were determined in medium containing 1 mM Ca 2+ by lysing then probed with specific antibodies and horseradish peroxithe cells with 0.5% Triton X-100 for R max , followed by the dase-conjugated goat anti-mouse IgG or anti-rabbit IgG (Bioaddition of an excess of EGTA for R min . Rad, Ivry sur Seine, France) as secondary antibodies, using an enhanced chemiluminescence detection system (Amersham, Paris, France) on Cronex X-ray film (Du Pont de Nemours, Les PCR amplification of the region encoding for human Ulis, France). The same blots were reprobed in some experiSyk ments after stripping bound antibodies as previously reported. 17 Densitometric analysis were performed using a GS-670 Bio-Rad densitometer.
Total cellular RNA was prepared from Daudi cells (5 × 10 6 ) and B-CLL cells (20 × 10 6 ) according to a single-step guanidium isothiocyanate-phenol-chloroform extraction method (RNA.B, Bioprobe System, Montreuil sous Bois, France). The Immunoprecipitation of Syk precipitated RNA was vaccum-dried and cDNA was synthesized in a final volume of 35 l at 37°C for 1 h using 5 g of In immunoprecipitation experiments, Brij 96-soluble fractions from Daudi and B-CLL cells were incubated for 2 h at 4°C total RNA with the Stratagene cDNA synthesis kit (Stratagene, Ozyme, Montigny-le-Bretonneux, France). The cDNA with anti-Syk antiserum (1/100 dilution). Immunoprecipitation was conducted with 30 l of packed protein A-sepharose CLsequence encoding human Syk was amplified by PCR using 5Ј and 3Ј oligonucleotides (Bioprobe System) as primers. The 4B (Sigma, Paris, France) for 1 h at 4°C. The samples were then washed three times with cold lysis buffer, and the upper and lower primers were 5Ј-TGACGCTGGAAGACAAA-GAA-3Ј and 5Ј-GAGGGAGGTGGCTGACAATC-3Ј, respectimmune complexes were boiled in SDS sample buffer. The precipitated proteins were separated by SDS/PAGE in 8 or ively, amplifying an 870-bp fragment. Thirty-six PCR cycles were performed in a Biometra Personal Cycler (Biometra, Gö t-10% polyacrylamide gels and subjected to Western blotting with phosphotyrosine-or Syk-specific antibodies.
tingen, Germany) in a final volume of 50 l containing 200 M dNTP, 10 M each primer, 1 U Taq polymerase (Appligene, Illkirch, France) and 250 ng of cDNA. Each cycle consisted of denaturation at 94°C for 5 min, hybridization at
In vitro kinase assays on Syk immunoprecipitates 55°C for 2 min and elongation at 72°C for 1 min. The reaction was terminated by a final extension step at 72°C for 6 min. Syk immunoprecipitates prepared as described above were washed once with a buffer (phosphorylation buffer) containing
As an internal control, actin primers (␤-actin primer set; Stratagene, La Jolla, CA, USA) were used in parallel. The amplified Pipes 50 mM pH 6.8, MnCl 2 10 mM, MgCl 2 10 mM, sodium orthovanadate 50 M, aprotinine 50 U/ml and PMSF 1 mM.
products were electrophoresed and visualized on ethidium bromide-stained 2% agarose gels. The gels were scanned with After 2 min of equilibration at 30°C, the reaction was started by addition on the protein A of 30 l of phosphorylation a UVP Image Store 5000 device (Cambridge, UK). Daudi cells used as a positive control in all these experiments gave values of 29.84 ± 4.14 and 3.69 ± 0.69 with the two cal-B cells. As previously reported, 13 this could be due to degradation of the kinase into lower molecular weight forms that culation methods, respectively. Together, these results demonstrated impaired tyrosine phosphorylation of Syk in noncould correspond to the 37 kDa band recognized by the antiSyk antiserum in these cells only. This problem was frequently responsive B-CLL cells, a feature corresponding to an impaired Ca 2+ response to anti-stimulation. However, it was encountered and prompted us to use the EBV-transformed Daudi B cell line as a control in subsequent experiments.
Results
noteworthy that most of the non-responding B-CLL cells still showed a moderate increase in Syk labelling (see also To investigate further Syk phosphorylation, a polyclonal antiserum against human Syk was used to examine the level Figure 5 ). Finally, the basal level of tyrosine-phosphorylated and 5), this could suggest that the two biochemical events do not coincide necessarily. However, the very high in vitro basal One possible explanation for the low Syk phosphorylation in some B-CLL cells was a low level of Syk protein in the cell autophosphorylation of Syk (as compared to Daudi cells), usually noticed in most B-CLL cells, may also be responsible. extracts, a deficit evoked in a recent study.
11 Our results argue against this explanation. For instance, the amount of Syk was Nevertheless, one important conclusion to be drawn from these data is that the kinase activity of Syk, as measured by assessed in Figure 2b , using the same blots as in Figure 2a , after stripping bound anti-phosphotyrosine antibodies and its capacity to phosphorylate itself, is seemingly fully conserved in the non-responding B-CLL cells as shown here with subsequent blotting with anti-Syk antibodies. Despite the striking difference in Syk tyrosine phosphorylation, the amount of the low responder LEM and an additional donor, PAU, exhibiting a low tyrosine phosphorylation of Syk and a low Ca 2+ the kinase was similar in the different B-CLL cells. Surprisingly, it was lower in strongly responding Daudi B cells. This response to anti-stimulation (not shown). The same results were obtained with tubulin used as an exogeneous substrate finding must be emphasized, as the tyrosine phosphorylation of Syk was always stronger in Daudi B cells after stimulation (not shown). They demonstrate that intrinsic activity of Syk is maintained in vitro in low responders, and that a defect at the of the B cell receptor. It confirmed the results in Figure 1 (right panel), in which the total extracts of different B-CLL cells were enzymatical level to explain the low phosphorylation observed in in vivo conditions is improbable. directly probed with anti-Syk antiserum.
Syk mRNA was also analyzed by means of RT-PCR. Figure 3 As shown in Figure 5 (left panel), tyrosine-phosphorylated proteins migrating in the 145 kDa region were repeatedly shows the results of an experiment with B-CLL cells from the normally responding patient CLA and the poorly responding observed in Syk immunoprecipitates from anti-stimulated Daudi B cells. A similar association was observed with cells patient CHA. Daudi B cells were again used as controls, and the housekeeping ␤-actin gene was amplified in parallel. No from the good Ca 2+ responder, CLA. We suspected that the band corresponded to PLC␥, as Sillman et al 19 have reported significant differences were found between the two donors. could therefore represent Syk ( Figure 5 , right panel). The same bands were observed when using the cell lysate from donor The impaired response of some B-CLL cells to anti-stimulation may also originate from a qualitative defect of Syk. We CLA, although the 70 kDa protein was more evident. However, Syk was barely detectable by direct Western blotting therefore investigated Syk enzymatic activity by measuring the autophosphorylation of the kinase in in vitro kinase assays with its specific antiserum in the different PLC␥-2 immunoprecipitates, suggesting a very weak association (not shown). performed with Syk immunoprecipitates. As shown in Figure 4 , we could note an increase labelling of Syk after antiCrowley et al 20 recently reported that, in human B cells, a tyrosine-phosphorylated protein with an apparent MW of stimulation of Daudi B cells. By contrast, no significant increase was observed with cells from the good responder 140-145 kDa co-immunoprecipitated with Syk after BCR stimulation. This protein, described as a partner of Grb2 and CLA, and there was even a decrease after stimulation. Since events. 24 We therefore focused this study on the functioning of Syk in B-CLL cells.
One major finding was the severely impaired tyrosine phosphorylation of Syk in B-CLL cells with low Ca 2+ responses to anti-stimulation. Studies on the BCR activation pathway have led to the tentative conclusion that Syk is mandatory for BCR-mediated signaling events. Our understanding of how Syk intervenes in the B cell activation process has recently improved. One consequence of receptor ligation appears to be that Syk can associate with the BCR. This binding would be mediated by the tandem SH2 domains of Syk recruited to the dual phosphotyrosine site appearing in the conserved ITAM motifs of the receptor signaling Ig␣ and ␤ chains of the BCR.
14, 15 Such an association would trigger tyrosine phosphorylation of the kinase, presumably by an autophosphorylation or transphosphorylation mechanism, as recently proposed for the related PTK ZAP-70 in T cells. 25 A prominent role was assigned to this sustained phosphorylation of the kinase on tyrosine residues in propagating the signal into the cells, presumably by generating specific binding sites for SH2 domain-containing proteins. Accordingly, we always observed a very good correlation between the level of tyrosine-phosphorylated Syk and responsiveness to BCR ligation. It can therefore be assumed that the alterations of downstream elements of the BCR activation pathway mainly result from the defect in Syk tyrosine phosphorylation. This would negatively influence the 'docking' function of the kinase, reducing the recruitment and tyrosine phosphorylation by the kinase of key molecules in the BCR signaling cascade. A good illustration is the enzymes of the PLC␥ family. These molecules probably associate with tyrosine-phosphorylated Syk in activated B cells through a SH2-type interaction 19 and are potential substrates defects in some B-CLL cells, is likely to result from the altered
The cDNA sequence encoding human Syk was then amplified by PCR tyrosine phosphorylation of Syk. Clearly, the latter could also with specific primers. As an internal control of the assays, ␤-actin impair Syk binding to the SH2 domain of Src kinases, which primers were amplified in parallel using the same amount of cDNA.
can be found complexed with Syk in B cells in vivo. 27, 28 This
Identical volumes of amplification products for each cell type were may also negatively influence the phosphorylation by Src PTK run on an agarose gel and stained with ethidium bromide. A 100-of specific signaling molecules recruited at the level of tyrobasepair ladder was run in parallel. By scanning densitometry, we calculated that the ratio between the ␤-actin and Syk bands was 1.62 sine-phosphorylated Syk. tein deficiency might be found in a much larger panel of patients, given the great heterogeneity of this malignancy, but no clear relationship between the level of Syk protein in cell Shc, 21, 22 could also account for most of the band at 145 kDa in Syk precipitates. Whether it is the inositol polyphosphate 5-extracts and the responding or non-responding nature of the cell was found here. We were, however, surprised to observe phosphatase SHIP, a 145-kDa protein tyrosine phosphorylated after stimulation of the BCR and associated with the adapter that the Daudi B cell line, widely used as a model of BCR signaling, contained far less Syk than B-CLL cells. Although protein Shc, 23 is a tempting hypothesis. However that may be, it should be emphasized that no such associations were visible we cannot rule out different susceptibility to detergent extraction, the phenomenon was confirmed at the mRNA level. By in non-responding B-CLL cells from donor MIG, in which tyrosine phosphorylation of Syk was clearly defective ( Figure 5) . contrast, Syk was always more strongly tyrosine phosphorylated in Daudi B cells than in highly responding B-CLL cells.
Coincidentally, anti--stimulated increased catalytic activity of Syk was only observed in the former. This might point to Discussion more efficient coupling of the kinase, possibly linked to the stronger expression of the BCR in this cell line, and provides Given the great heterogeneity of CLL and the complexity of the signaling cascades involved in the B cell activation proindirect evidence that parameters other than the amount of Syk can influence the B cell response. cess, the defect responsible for the altered functional response to BCR stimulation in some B-CLL cells has not yet been identThe BCR is a multimolecular complex in which the Ig noncovalently associated CD79a/CD79b heterodimer has a ified. Previous studies have suggested, however, that it is very proximal, and probably involves an early signal transduction prominent function. Indeed, as mentioned above, CD79a and CD79b bear the so-called ITAM motif that is required to coudefect.
9-11 The Syk cytoplasmic protein-tyrosine kinase is essential for coupling the BCR to most downstream signalling ple activated BCR to the downstream signaling cascade. Pre-
Figure 4
Low and high Ca 2+ responding B-CLL cells exhibit a high basal in vitro kinase activity of Syk, not increased after BCR stimulation. Syk immunoprecipitates were performed as in Figure 2 and the immunoprecipitates then subjected to in vitro kinase assay using ␥-32 P ATP. The proteins were then separated by SDS-PAGE, the gel dried and quantitation of the radioactivity in Syk directly measured on numeric images obtained from actual counting of ␤-particles emitted. Shown are two separate experiments. vious studies have focused on the expression of CD79a and although reduced expression of the two chains in B-CLL cells, has been observed using antibodies specific for each molCD79b in human B cell malignancies, including CLL. Studying 25 cases of acute lymphoblastic leukemia of B cell origin ecule. 30 Lankester et al 11 recently showed that BCR structure is identical in responsive and unresponsive B-CLL cells. These (B-ALL) and five cases of multiple myeloma by immunochemical methods, Mason et al 29 found that immature B cells and findings do not rule out the possibility that the heterodimer is present but not fully functional in unresponsive or poorly plasma cells expressed CD79a but not CD79b. Significant, reason for this defective coupling is unclear. As mentioned 
